+Article 44 1

Article 44 1

1.   Where a market surveillance authority of one Member State has reason to believe that an EHR system poses a risk to the health, safety or rights of natural persons or to the protection of personal data, that market surveillance authority shall carry out an evaluation in relation to the EHR system concerned covering all relevant requirements laid down in this Regulation. The manufacturer, the manufacturer’s authorised representative and all other relevant economic operators shall cooperate as necessary with the market surveillance authority for that purpose and take all appropriate measures to ensure that the EHR system concerned no longer poses that risk when placed on the market or to recall or withdraw the EHR system from the market within a reasonable period.

1. Pārskats

,
Nosaukums Regulējums

1.1 Atsauces

1.2 Identificētās prasības

1.3 Saistītie standarti

2. Identificētās prasības

Prasības
Avots Prasība

3. Saistītie standarti

Standarti
Avots Prasība
  • Builddate: 05.03.2025 00:00:00 -Doknr: CELEX:32025R0327
  • EULAW -

    EN: Legal acts of the European Union from EUR-Lex, https://eur-lex.europa.eu/. © European Union. Re-use is authorised by Decision 2011/833/EU, provided the source is acknowledged; the consolidated texts are licensed under CC BY 4.0 (EUR-Lex legal notice). Divided into sections and converted into the GRCA format, the wording unchanged. Only the legislation published in the Official Journal of the European Union is deemed authentic.

    DE: Rechtsakte der Europäischen Union aus EUR-Lex, https://eur-lex.europa.eu/. © Europäische Union. Weiterverwendung nach Beschluss 2011/833/EU mit Quellenangabe gestattet; die konsolidierten Fassungen stehen unter CC BY 4.0 (Rechtlicher Hinweis von EUR-Lex). In Abschnitte aufgeteilt und in das GRCA-Format umgewandelt, der Wortlaut unverändert. Verbindlich sind allein die im Amtsblatt der Europäischen Union veröffentlichten Rechtsakte.